Adaptimmune to Report Q1 2024 Financial and Business Updates on | The Kingston Whig Standard

Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 1, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Canada ,Julip Miller ,Dana Lynch ,Corporate Communications ,Newsfile Corp ,Nasdaq ,Exchange Commission ,Corporate Affairs ,Business Updates ,United Kindgom ,Adaptimmune Therapeutics ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Senior Director ,